CN101224186A - 双氯芬酸依泊胺凝胶剂、其制备方法及药物用途 - Google Patents
双氯芬酸依泊胺凝胶剂、其制备方法及药物用途 Download PDFInfo
- Publication number
- CN101224186A CN101224186A CNA2008100329780A CN200810032978A CN101224186A CN 101224186 A CN101224186 A CN 101224186A CN A2008100329780 A CNA2008100329780 A CN A2008100329780A CN 200810032978 A CN200810032978 A CN 200810032978A CN 101224186 A CN101224186 A CN 101224186A
- Authority
- CN
- China
- Prior art keywords
- gel
- diclofenac epolamine
- diclofenac
- curative effect
- refers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960000942 diclofenac epolamine Drugs 0.000 title claims abstract description 46
- DCERVXIINVUMKU-UHFFFAOYSA-N diclofenac epolamine Chemical compound OCC[NH+]1CCCC1.[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCERVXIINVUMKU-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title description 3
- 235000015110 jellies Nutrition 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 10
- 208000002193 Pain Diseases 0.000 claims abstract description 6
- 239000006184 cosolvent Substances 0.000 claims abstract description 6
- 210000003205 muscle Anatomy 0.000 claims abstract description 6
- 210000004872 soft tissue Anatomy 0.000 claims abstract description 6
- 239000004094 surface-active agent Substances 0.000 claims abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 36
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 19
- 229920002125 Sokalan® Polymers 0.000 claims description 19
- 229960001631 carbomer Drugs 0.000 claims description 19
- 239000003981 vehicle Substances 0.000 claims description 15
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 14
- 230000008961 swelling Effects 0.000 claims description 13
- -1 carbon chain fatty acid triglycerides Chemical class 0.000 claims description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 7
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 7
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical class CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000007872 degassing Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 235000014593 oils and fats Nutrition 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 2
- 206010006784 Burning sensation Diseases 0.000 claims description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 2
- 239000001828 Gelatine Substances 0.000 claims description 2
- 208000006011 Stroke Diseases 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 230000000146 antalgic effect Effects 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 229960004926 chlorobutanol Drugs 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 229960004592 isopropanol Drugs 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 10
- 239000000758 substrate Substances 0.000 abstract description 3
- 230000001808 coupling effect Effects 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000003974 emollient agent Substances 0.000 abstract 1
- 239000004519 grease Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 206010015150 Erythema Diseases 0.000 description 15
- 206010070834 Sensitisation Diseases 0.000 description 15
- 231100000321 erythema Toxicity 0.000 description 15
- 230000008313 sensitization Effects 0.000 description 15
- 206010030113 Oedema Diseases 0.000 description 12
- 239000000546 pharmaceutical excipient Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 210000002683 foot Anatomy 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 235000013599 spices Nutrition 0.000 description 6
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000035617 depilation Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 229960001259 diclofenac Drugs 0.000 description 4
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 229960001193 diclofenac sodium Drugs 0.000 description 3
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000002085 irritant Substances 0.000 description 3
- 231100000021 irritant Toxicity 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229960005466 diclofenac diethylammonium Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 101000905241 Mus musculus Heart- and neural crest derivatives-expressed protein 1 Proteins 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | 红斑 | 水肿 | 致敏率(%) | 反应均值 | |
6h | 双氯芬酸依泊胺凝胶剂 | 0×10 | 0×10 | 0 | 0 |
赋形剂 | 0×10 | 0×10 | 0 | 0 | |
二硝基氟苯 | 1×32×7 | 0×61×4 | 1 00 | 2.3 | |
24h | 双氯芬酸依泊胺凝胶剂 | 0×10 | 0×10 | 0 | 0 |
赋形剂 | 0×10 | 0×10 | 0 | 0 | |
二硝基氟苯 | 1×52×5 | 0×61×4 | 1 00 | 1.3 | |
48h | 双氯芬酸依泊胺凝胶剂 | 0×10 | 0×10 | 0 | 0 |
赋形剂 | 0×10 | 0×10 | 0 | 0 | |
二硝基氟苯 | 0×61×4 | 0×10 | 40 | 0.4 | |
72h | 双氯芬酸依泊胺凝胶剂 | 0×10 | 0×10 | 0 | 0 |
赋形剂 | 0×10 | 0×10 | 0 | 0 | |
二硝基氟苯 | 0×10 | 0×10 | 0 | 0 |
组别 | 用量(g) | 致炎前足跖体积(ml) | 鼠左后足跖容积差(ΔV,ml) | |||
1h | 2h | 4h | 6h | |||
对照组 | 0.1g/次×3次 | 1.02±0.11 | 0.33±0.05 | 0.49±0.10 | 0.42±0.07 | 0.29±0.12 |
实施例1 | 0.1g/次×3次 | 1.08±0.08 | 0.35±0.08 | 0.52±0.14 | 0.40±0.21 | 0.25±0.11 |
实施例2 | 0.1g/次×3次 | 1.05±0.09 | 0.35±0.06 | 0.32±0.10 | 0.24±0.12 | 0.25±0.09 |
实施例3 | 0.1g/次×3次 | 1.10±0.05 | 0.30±0.10 | 0.28±0.13 | 0.25±0.08 | 0.26±0.06 |
实施例4 | 0.1g/次×3次 | 1.04±0.10 | 0.26±0.11 | 0.17±0.05* | 0.13±0.07* | 0.16±0.08* |
扶他林 | 0.1g/次×3次 | 1.09±0.05 | 0.31±0.05 | 0.28±0.09 | 0.24±0.04 | 0.22±0.10 |
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100329780A CN101224186B (zh) | 2008-01-23 | 2008-01-23 | 双氯芬酸依泊胺凝胶剂、其制备方法及药物用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100329780A CN101224186B (zh) | 2008-01-23 | 2008-01-23 | 双氯芬酸依泊胺凝胶剂、其制备方法及药物用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101224186A true CN101224186A (zh) | 2008-07-23 |
CN101224186B CN101224186B (zh) | 2010-12-08 |
Family
ID=39856532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100329780A Active CN101224186B (zh) | 2008-01-23 | 2008-01-23 | 双氯芬酸依泊胺凝胶剂、其制备方法及药物用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101224186B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991858B (zh) * | 2009-08-18 | 2012-06-27 | 天津京英透皮材料科技开发有限公司 | 新型外用辅料及其制备方法 |
WO2014009793A1 (en) | 2012-07-11 | 2014-01-16 | Glycores 2000 S.R.L. | Diclofenac solution for external use |
CN105395544A (zh) * | 2014-08-23 | 2016-03-16 | 南京海纳医药科技有限公司 | 双氯芬酸依泊胺凝胶制备方法及药物用途 |
CN105878214A (zh) * | 2014-08-23 | 2016-08-24 | 南京海纳医药科技有限公司 | 一种含双氯芬酸依泊胺的透皮贴剂及其制备方法 |
WO2023180792A1 (en) | 2022-03-25 | 2023-09-28 | Glycores 2000 Srl | Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof |
-
2008
- 2008-01-23 CN CN2008100329780A patent/CN101224186B/zh active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991858B (zh) * | 2009-08-18 | 2012-06-27 | 天津京英透皮材料科技开发有限公司 | 新型外用辅料及其制备方法 |
WO2014009793A1 (en) | 2012-07-11 | 2014-01-16 | Glycores 2000 S.R.L. | Diclofenac solution for external use |
CN105395544A (zh) * | 2014-08-23 | 2016-03-16 | 南京海纳医药科技有限公司 | 双氯芬酸依泊胺凝胶制备方法及药物用途 |
CN105878214A (zh) * | 2014-08-23 | 2016-08-24 | 南京海纳医药科技有限公司 | 一种含双氯芬酸依泊胺的透皮贴剂及其制备方法 |
WO2023180792A1 (en) | 2022-03-25 | 2023-09-28 | Glycores 2000 Srl | Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101224186B (zh) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101224186B (zh) | 双氯芬酸依泊胺凝胶剂、其制备方法及药物用途 | |
CN104010635A (zh) | 包含trpv1选择性激动剂的止痛组合物及其制备和应用 | |
CN108283620A (zh) | 一种磷酸二酯酶-4抑制剂的局部药物组合物及其制备方法 | |
WO2014059880A1 (zh) | 一种制备治疗妇科炎症的石榴皮多酚凝胶剂的方法 | |
WO2022178983A1 (zh) | 一种天然药物的外用制剂、制备方法及其应用 | |
CN1322895C (zh) | 一种中药凝胶剂及其制备方法 | |
RU2496476C1 (ru) | Средство наружной терапии для больных атопическим дерматитом | |
CN103099844A (zh) | 一种治疗婴幼儿湿疹的中药组合物 | |
CN102133175A (zh) | 苦杏仁苷凝胶剂及其制备方法和该凝胶剂的医药用途 | |
CN102283899A (zh) | 一种中药外用制剂及其用途 | |
CN101991585A (zh) | 治疗类风湿性关节炎的透皮吸收涂膜剂及其制备方法 | |
CN103041054B (zh) | 一种中药止痒凝胶剂及制备方法 | |
CN105687125A (zh) | 一种用于治疗皮肤病的硅凝胶 | |
CN105963367A (zh) | 一种肛肠外科手术术前护理用凝胶剂及其制备方法 | |
US10960011B2 (en) | Compositions for the treatment of ischemic ulcers and stretch marks | |
CN102961558B (zh) | 一种贴剂及其制备方法 | |
CN105395544A (zh) | 双氯芬酸依泊胺凝胶制备方法及药物用途 | |
CN102961396A (zh) | 透明质酸金属盐在制备治疗皮肤病药物中的应用、其药物组合物及其制备方法 | |
ES2932359T3 (es) | Formulación basada en N-acetilcisteína y urea para el tratamiento de trastornos dermatológicos | |
CN113018254A (zh) | 一种用于治疗原发性痛经的布洛芬液晶凝胶经皮制剂及其制备方法 | |
CN104274494B (zh) | 一种美洲大蠊外用制剂及其制备方法 | |
CN101837068B (zh) | 椒目仁油喷雾剂的制备工艺和应用 | |
CN101518582A (zh) | 一种治疗骨伤病的中药乳膏及制备方法 | |
CN102205091B (zh) | 一种治疗痛证或痹症的药物组合物及其制备方法和用途 | |
CN103316331A (zh) | Sod在制备治疗皮肤病药物中的应用、其药物组合物、该药物组合物的应用及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190510 Address after: Room 304-12, 665 Zhangjiang Road, Shanghai Free Trade Pilot Area, Pudong New Area, Shanghai 201210 Patentee after: Shanghai Huilun Pharmaceutical Technology Co.,Ltd. Address before: Room 650-10, Building No. 2, 351 Guoshoujing Road, Zhangjiang High-tech Park, Shanghai, 201203 Patentee before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190814 Address after: Room 650-10, Building No. 2, 351 Guoshoujing Road, Pudong New Area Free Trade Pilot Area, Shanghai, 201203 Patentee after: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Address before: Room 304-12, 665 Zhangjiang Road, Shanghai Free Trade Pilot Area, Pudong New Area, Shanghai 201210 Patentee before: Shanghai Huilun Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 650-10, Building No. 2, 351 Guoshoujing Road, Pudong New Area Free Trade Pilot Area, Shanghai, 201203 Patentee after: Shanghai Hui Bio Technology Co.,Ltd. Address before: Room 650-10, Building No. 2, 351 Guoshoujing Road, Pudong New Area Free Trade Pilot Area, Shanghai, 201203 Patentee before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211222 Address after: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Hui Bio Technology Co.,Ltd. Patentee after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: Room 650-10, building 2, 351 GuoShouJing Road, Pudong New Area pilot Free Trade Zone, Shanghai 201203 Patentee before: Shanghai Hui Bio Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 200241 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Huilun Pharmaceutical Co.,Ltd. Patentee after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee before: Shanghai Hui Bio Technology Co.,Ltd. Patentee before: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |